Johnson & Johnson’s (J&J) vaccine candidate appears to protect against COVID-19 with just one shot of the dose.
- Johnson & Johnson says trial results show its one-shot vaccine is 66 per cent effective against COVID-19
- While promising, it is still behind many rivals who are using a two-shot vaccine
- The company says trying to create a vaccine which requires one shot is worthwhile as the virus continues to spread
The single-shot option is not as strong as some of its two-shot rivals, however…